ANUBL1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.55809817772956E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.88729998296111E-09 |
Normal-vs-Stage2 |
1.956350E-03 |
Normal-vs-Stage3 |
2.29259999873221E-08 |
Normal-vs-Stage4 |
3.66330299428341E-11 |
Stage1-vs-Stage2 |
7.222800E-01 |
Stage1-vs-Stage3 |
2.971000E-01 |
Stage1-vs-Stage4 |
4.318300E-02 |
Stage2-vs-Stage3 |
3.281000E-01 |
Stage2-vs-Stage4 |
1.210030E-01 |
Stage3-vs-Stage4 |
4.517800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.3545054794738E-11 |
Normal-vs-AfricanAmerican |
5.81779999953014E-07 |
Normal-vs-Asian |
2.753800E-01 |
Caucasian-vs-AfricanAmerican |
9.825200E-01 |
Caucasian-vs-Asian |
2.505600E-01 |
AfricanAmerican-vs-Asian |
1.810400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.58262292160316E-12 |
Normal-vs-Female |
5.35610000018671E-07 |
Male-vs-Female |
1.236320E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.19579999996655E-06 |
Normal-vs-Age(41-60Yrs) |
3.22760040916137E-10 |
Normal-vs-Age(61-80Yrs) |
1.57680002388361E-09 |
Normal-vs-Age(81-100Yrs) |
9.50330000000221E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.496600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.046600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.243000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.088200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.672800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.064000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.601700E-02 |
Normal-vs-Grade 2 |
1.81980000002469E-06 |
Normal-vs-Grade 3 |
3.79596354349587E-12 |
Normal-vs-Grade 4 |
5.11229947264269E-11 |
Grade 1-vs-Grade 2 |
7.914000E-01 |
Grade 1-vs-Grade 3 |
1.592550E-01 |
Grade 1-vs-Grade 4 |
7.989500E-02 |
Grade 2-vs-Grade 3 |
1.635670E-02 |
Grade 2-vs-Grade 4 |
5.117300E-03 |
Grade 3-vs-Grade 4 |
2.767800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.23660000001169E-06 |
Normal-vs-ccB subtype |
2.08369987930723E-10 |
ccA subtype-vs-ccB subtype |
9.060100E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.47149997637075E-09 |
Normal-vs-N1 |
6.985700E-04 |
N0-vs-N1 |
8.529600E-01 |
|
|